Regulus Therapeutics Inc.

Updates from The Motley Fool

Latest updates on Regulus Therapeutics from
This Week in Biotech

An FDA approval, a promising drugs' late-stage failure, and a biopharmaceutical company reinventi...

Stock Performance

View Interactive RGLS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Regulus Therapeutics.
Current Price: $1.25
Prev Close: $1.20
Open: $1.20
Bid: $1.15
Ask: $1.30
Day's Range: $1.15 - $1.30
52wk Range: $0.94 - $8.90
Volume: 869,258
Avg Vol 864,022
Market Cap: $66M
P/E (ttm): -0.77
EPS (ttm): ($1.55)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Regulus Therapeutics.
CAPS Rating 3 out of 5
31 Outperform
15 Underperform
CAPS All Stars
13 Outperform
3 Underperform

How do you think Regulus Therapeutics will perform against the market?

You pick for Regulus Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kleanthis Xanthopoulos, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Regulus Therapeutics.

Regulus Therapeutics Inc.

  • Exchange: NASDAQ